Text to be removed highlighted in red.
1 New Paragraph; Controlled Drug Act; Dealing In or Possessing Prescription Drugs. Amend RSA 318:42 by inserting after paragraph VII-b the following new paragraph:
VII-c. The dispensing of up to a 30-day supply of noncontrolled oral anti-cancer medication by a licensed health care professional legally authorized to prescribe and administer medications to a patient under a provider's care or supervision so long as the following criteria are met:
(a) The dispensing clinic maintains on staff a full-time licensed pharmacist who is available for consultation with the prescribing provider and the patient.
(b) In-office dispensing is conducted in a way consistent with United States Pharmacopeia standards as well as all relevant state and federal laws or rules.
2 Pharmacists and Pharmacies; Display of Licenses. Amend RSA 318:28 to read as follows:
318:28 Display of Licenses. All licenses as pharmacists shall at all times be conspicuously displayed in the pharmacy where the licensee is engaged as such.
3 Pharmacists and Pharmacies; Licensure of Pharmacies. Amend RSA 318:39 to read as follows:
318:39 Application; Display. Application for a permit shall be made in such manner and in such form as the board may determine. The permit shall at all times be exposed in a conspicuous place in the pharmacy for which it is issued.
4 Pharmacists and Pharmacies; Licensed Pharmacists; Remote Processing. Amend RSA 318:15-d, I to read as follows:
I. New Hampshire licensed pharmacists, certified New Hampshire pharmacy technicians, or registered New Hampshire pharmacy interns may engage in remote processing, provided that all work requiring pharmacist supervision is supervised by a licensed pharmacist through electronic or other remote means.
5 Controlled Drug Act; Labels. Amend RSA 318-B:13, II to read as follows:
II. Whenever a pharmacist dispenses any controlled drug on prescription issued by a practitioner, he or she shall affix to the container in which such drug is dispensed a label showing the name, address, and registry number of the pharmacy and name or the initials of the pharmacist; the name of the prescribing practitioner; the prescription identification number; the name of the patient; the date dispensed; any directions as may be stated on the prescription; and the name and strength and quantity of the drug dispensed. All drugs dispensed to a patient that have been filled using a centralized prescription processing system shall bear a label containing an identifiable code that provides a complete audit trail of the dispensing of the drug and pharmaceutical care activities. No person shall alter, deface, or remove any label so affixed.
6 Pharmacists and Pharmacies; Definitions; Practice of Pharmacy. RSA 318:1, XIV is repealed and reenacted to read as follows:
XIV. "Practice of pharmacy" means the provision of patient care services by a pharmacist based on their education, training, and experience, and determined by practice setting, including but not limited to:
(a) The interpretation and evaluation of prescription orders;
(b) The compounding, dispensing, labeling, administering, and distribution of drugs and devices;
(c) The selection, evaluation, and monitoring of drug and drug-related therapies;
(d) The performance of drug utilization reviews and medication therapy management;
(e) The participation in collaborative pharmacy practice and collaborative pharmacy practice agreements as defined in RSA 318:1, XXVI - XXVII, and RSA 318:16-a;
(f) The prescribing, ordering, administering, and interpretation of laboratory tests, controlled and noncontrolled drugs, and devices within the pharmacist's scope of practice;
(g) The education and counseling of patients and health care professionals on the therapeutic use, potential hazards, and outcomes of drugs and devices;
(h) The maintenance of appropriate records and the safe storage and handling of drugs and devices; and
(i) Any other professional acts, services, operations, or transactions necessary to the operation and management of pharmacy practice.
7 Pharmacy Board; Rulemaking Authority. Amend RSA 318:5-a, XVII to read as follows:
XVII. The education and training standards and other requirements for pharmacists who, pursuant to prescriber-approved protocol *:
(a)* administer prescription medications , including influenza immunizations.
(b) Engage in collaborative pharmacy practices.
8 Licensed Pharmacists; Standards for Collaborative Pharmacy Practice. Amend RSA 318:16-a, I(c) to read as follows:
(c) Have the knowledge base necessary for proper monitoring, including, but not limited to, associated disease states, relevant laboratory tests, adverse events, drug and food interactions, safety, and efficacy. Depending upon the complexity of the services being provided, the pharmacist may be required to have additional credentials or training and shall demonstrate the receipt of approval by the board of pharmacy.
9 Effective Date. This act shall take effect 60 days after its passage.
Text to be added highlighted in green.
1 New Paragraph; Controlled Drug Act; Dealing In or Possessing Prescription Drugs. Amend RSA 318:42 by inserting after paragraph VII-b the following new paragraph:
VII-c. The dispensing of up to a 30-day supply of noncontrolled oral anti-cancer medication by a licensed health care professional legally authorized to prescribe and administer medications to a patient under a provider's care or supervision so long as the following criteria are met:
(a) The dispensing clinic maintains on staff a full-time licensed pharmacist who is available for consultation with the prescribing provider and the patient.
(b) In-office dispensing is conducted in a way consistent with United States Pharmacopeia standards as well as all relevant state and federal laws or rules.
2 Pharmacists and Pharmacies; Display of Licenses. Amend RSA 318:28 to read as follows:
318:28 Availability of Licenses. All licenses as pharmacists shall be readily retrievable in the pharmacy where the licensee is engaged as such.
3 Pharmacists and Pharmacies; Licensure of Pharmacies. Amend RSA 318:39 to read as follows:
318:39 Application; Display. Application for a permit shall be made in such manner and in such form as the board may determine. The permit shall at all times be posted in the pharmacy for which it is issued.
4 Pharmacists and Pharmacies; Licensed Pharmacists; Remote Processing. Amend RSA 318:15-d, I to read as follows:
I. New Hampshire licensed pharmacists, licensed advanced pharmacy technicians, certified New Hampshire pharmacy technicians, or registered New Hampshire pharmacy interns may engage in remote processing, provided that all work requiring pharmacist supervision is supervised by a licensed pharmacist through electronic or other remote means.
5 Controlled Drug Act; Labels. Amend RSA 318-B:13, II to read as follows:
II. Whenever a pharmacist dispenses any controlled drug on prescription issued by a practitioner, he or she shall affix to the container in which such drug is dispensed a label showing the name, address, and registry number of the pharmacy ; the name of the prescribing practitioner; the prescription identification number; the name of the patient; the date dispensed; any directions as may be stated on the prescription; and the name and strength and quantity of the drug dispensed. All drugs dispensed to a patient that have been filled using a centralized prescription processing system shall bear a label containing an identifiable code that provides a complete audit trail of the dispensing of the drug and pharmaceutical care activities. No person shall alter, deface, or remove any label so affixed.
6 Pharmacists and Pharmacies; Definitions; Practice of Pharmacy. RSA 318:1, XIV is repealed and reenacted to read as follows:
XIV. "Practice of pharmacy" means the provision of patient care services by a pharmacist based on their education, training, and experience, and determined by practice setting, including but not limited to:
(a) The interpretation and evaluation of prescription orders;
(b) The compounding, dispensing, labeling, administering, and distribution of drugs and devices;
(c) The selection, evaluation, and monitoring of drug and drug-related therapies;
(d) The performance of drug utilization reviews and medication therapy management;
(e) The participation in collaborative pharmacy practice and collaborative pharmacy practice agreements as defined in RSA 318:1, XXVI - XXVII, and RSA 318:16-a;
(f) The prescribing, ordering, administering, and interpretation of laboratory tests, controlled and noncontrolled drugs, and devices within the pharmacist's scope of practice;
(g) The education and counseling of patients and health care professionals on the therapeutic use, potential hazards, and outcomes of drugs and devices;
(h) The maintenance of appropriate records and the safe storage and handling of drugs and devices; and
(i) Any other professional acts, services, operations, or transactions necessary to the operation and management of pharmacy practice.
7 Pharmacy Board; Rulemaking Authority. Amend RSA 318:5-a, XVII to read as follows:
XVII. The education and training standards and other requirements for pharmacists who, pursuant to prescriber-approved protocol , administer prescription medications outside the parameters of a collaborative pharmacy practice agreement , including influenza immunizations.
8 Licensed Pharmacists; Standards for Collaborative Pharmacy Practice. Amend RSA 318:16-a, I(c) to read as follows:
(c) Have the knowledge base necessary for proper monitoring, including, but not limited to, associated disease states, relevant laboratory tests, adverse events, drug and food interactions, safety, and efficacy.
9 Effective Date. This act shall take effect 60 days after its passage.